Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AYTUthis companyAytu BioPharma, Inc.	$1.86	-1.85×	0.75×	0.46×	-4.17×	-322.8%	64.0%	-14.4%	-24.8%	-40.4%	-14.2%	12.3%	0.51×	1.87×	4.39×	1.13×	0.0%	4	-4.22	2	C
BFRIBiofrontera Inc.	$0.84	-0.55×	0.55×	0.14×	-0.61×	-3679.1%	78.7%	-21.9%	-25.3%	-100.5%	-53.8%	-230.5%	0.59×	0.03×	-20.24×	1.52×	0.0%	2	-6.17	1	C-
GOVXGeoVax Labs, Inc.	$0.17	-0.19×	1.07×	1.65×	-0.09×	3.5%	-628.0%	-869.3%	-862.3%	-561.2%	-463.5%	-524.2%	0.22×	0.1×	0×	2.74×	0.0%	2	-62.33	2	C+
NVNOenVVeno Medical Corporation	$6.52	-0.34×	0.25×	0×	-0.23×	-49.7%	0.0%	0.0%	0.0%	-71.8%	-75.1%	-231.9%	0.03×	0.12×	0×	13.58×	0.0%	1	-13.74	3	B-
TXMDTherapeuticsMD, Inc.	$1.69	-33.13×	0.7×	6.24×	-5.78×	-817.2%	100.0%	-139.4%	-18.8%	-2.1%	-12.5%	12.9%	0.23×	0.46×	-526.75×	3.02×	0.0%	4	-34.36	2	C+
Peer median	—	-0.45×	0.63×	0.89×	-0.42×	-433.5%	39.3%	-80.7%	-22.0%	-86.2%	-64.5%	-231.2%	0.22×	0.11×	-10.12×	2.88×	0.0%	2	-24.05	2	—